Agenda

Preliminary injunctions remain one of the most powerful enforcement mechanisms in the pharmaceutical and biotechnology patent litigation toolkit. Panellists in this session will examine recent key decisions and jurisdictional contrasts in preliminary injunction practice across Europe, the U.S. and other major international markets, using developments from 2026 as a lens through which to explore the strategies expected to shape how injunctive relief will be sought and opposed this year.

- Analyse the latest case law developments in the preliminary injunctions space across the UPC, national European courts, the U.S. and Brazil, along with their implications for litigation strategy.  

- Assess practical considerations for obtaining or resisting preliminary injunctions in different jurisdictions, including timing, evidence and commercial risk.  

- Understand how preliminary injunction decisions are shaping launch planning and broader patent enforcement strategies for pharmaceutical and biotechnology companies.